Kailera has introduced a new drug known as 'triple-G,' which appears to show considerable potential in its efficacy.
This development comes amid broader discussions in the biotech sector, particularly regarding advancements in longevity and health.
Additionally, the Chan Zuckerberg Biohub has been making strides with its AI protein model, contributing to the ongoing innovation in biotechnology.